Mercury Laboratories (BOM:538964) Days Sales Outstanding : 114.81 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Mercury Laboratories Days Sales Outstanding?

Mercury Laboratories's average Accounts Receivable for the three months ended in Mar. 2024 was ₹218.5 Mil. Mercury Laboratories's Revenue for the three months ended in Mar. 2024 was ₹173.7 Mil. Hence, Mercury Laboratories's Days Sales Outstanding for the three months ended in Mar. 2024 was 114.81.

The historical rank and industry rank for Mercury Laboratories's Days Sales Outstanding or its related term are showing as below:

BOM:538964' s Days Sales Outstanding Range Over the Past 10 Years
Min: 94.25 Med: 110 Max: 126.27
Current: 113.59

During the past 11 years, Mercury Laboratories's highest Days Sales Outstanding was 126.27. The lowest was 94.25. And the median was 110.00.

BOM:538964's Days Sales Outstanding is ranked worse than
80.92% of 996 companies
in the Drug Manufacturers industry
Industry Median: 72.035 vs BOM:538964: 113.59

Mercury Laboratories's Days Sales Outstanding increased from Mar. 2023 (100.33) to Mar. 2024 (114.81).

Mercury Laboratories Days Sales Outstanding Historical Data

The historical data trend for Mercury Laboratories's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mercury Laboratories Days Sales Outstanding Chart

Mercury Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

119.27

108.21

126.27

94.25

104.38

Mercury Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															100.33	106.41	106.11	141.08	114.81

Competitive Comparison of Mercury Laboratories's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Mercury Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mercury Laboratories's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mercury Laboratories's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Mercury Laboratories's Days Sales Outstanding falls into.

Mercury Laboratories Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Mercury Laboratories's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (213.653	+	218.51)	/	2 )	/	755.59	*	365
=	216.0815					/	755.59	*	365
=	104.38

Mercury Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	218.51)	/	1 )	/	173.672	*	365 / 4
=	218.51					/	173.672	*	365 / 4
=	114.81

Mercury Laboratories (BOM:538964) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Mercury Laboratories Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Mercury Laboratories's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Mercury Laboratories (BOM:538964) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mercury Laboratories Ltd (BOM:538964) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

Gorwa Road, 2/13-14, Gorwa Industrial estate, P.B. No. 3001, Vadodara, GJ, IND, 390016

Website

https://www.mercurylabs.com

Mercury Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and distribution of pharmaceutical drugs, herbs, and laboratory and surgical materials. The group produces medicines and formulations in the segments of pediatrics, obstetrics, gynecology, surgeon segment, multivitamin and nutrition supplements, antibiotics, and others. The company sells its products in India and internationally, of which key revenue is derived from sales made in India.

Mercury Laboratories (BOM:538964) Headlines

No Headlines